Novartis is required each year to submit data to the Centers for Medicare and Medicaid Services (CMS) Open Payments program (commonly known as the Sunshine Act) as an applicable manufacturer. CMS collects information about certain payments and other transfers of value from applicable manufacturers and group purchasing organizations (GPOs) to physicians and teaching hospitals. Open Payments is the federally run transparency program that collects information about these financial relationships and makes it available to the public annually.
Through the CMS Open Payments website, you can view information about Novartis Pharmaceuticals Corporation’s (NPC's) financial relationships with US Physicians and teaching hospitals, as well as the relationships that physicians and teaching hospitals maintain with other companies. You can read more about the Open Payments program here.
The 2017 NPC Research payments and transfers of value to US physicians and teaching hospitals that were submitted to CMS have been published on the Open Payments database. However, due to a technical issue with the 2017 NPC General Payments Report, only a small subset of this Report’s payments and transfers of value appear on the Open Payments database. We have worked with CMS to address this. In the meantime, to support our efforts to openly communicate payments and transfers of value to US physicians and teaching hospitals, NPC has voluntarily published all of the payments and transfers of value included in the 2017 General Payments Report on our website. You can view the 2017 General Payments Report here. NPC Research payments and transfers of value can be found on the CMS website.
To view NPC’s past disclosures of payments and transfers of value to US physicians and teaching hospitals related to speaking, advising, consulting, and other transfers of value:
Enter the company name “Novartis Pharmaceuticals Corporation” and click “Search”
Select “Novartis Pharmaceuticals Corporation” by clicking on the company name in the search results
The CMS search tool will then display a summary of Novartis Pharmaceuticals Corporation’s overall payment information. You will also have the ability to search and view more detailed payment information for individual physicians and teaching hospitals.
Novartis acquired certain oncology products from GlaxoSmithKline (GSK) in March 2015. Since the products were acquired by Novartis, GSK continued to provide certain payments and transfers of value associated with those products to Healthcare Professionals. Information about these financial relationships can also be viewed via the CMS website.
NPC believes that disclosing its payments related to interactions with physicians and related entities helps foster trust and supports our commitment to maintaining the highest ethical standards in the work we do. We are committed to transparency and to meeting all state and federal reporting requirements, including Open Payments, as well as the Corporate Integrity Agreement (CIA) which NPC entered into with the Office of the Inspector General for the Department of Health and Human Services in September 2010.
Questions? Contact NPC’s Customer Interaction Center at 866-356-8735 or [email protected].